经会阴超声早期肠壁厚度改善预测活动性溃疡性结肠炎治疗成功
这项单中心前瞻性研究纳入100例接受诱导治疗的活动性溃疡性结肠炎(UC)患者,评估经腹或经会阴超声早期变化能否预测第8周临床缓解。基线超声参数和生物标志物无预测价值,但经会阴超声测量的直肠肠壁厚度从基线至第1周的变化是第8周缓解的独立预测因子(每降低1mm的校正比值比为1.90,95%CI 1.22-2.95);在1周内未缓解亚组中,该变化的预测价值仍较高(AUC=0.77,95%CI 0.61-0.88)。
要点
- 基线超声参数和生物标志物不能预测第8周缓解。
- 经会阴超声直肠肠壁厚度第1周较基线降低与第8周缓解独立相关。
- 1周内未缓解者中,该厚度变化的预测AUC仍达0.77。
核心结论
- 经会阴超声测量的直肠肠壁厚度第1周改善可预测治疗成功,并可能有助于UC诱导治疗早期决策。
研究设计与样本
- 单中心前瞻性研究,纳入100例接受诱导治疗的活动性UC患者,分析第8周临床缓解的超声预测因素,并与基线、第1周和第8周测量的粪钙卫蛋白和C反应蛋白比较。
主要发现
- 100例中54例在第8周达到缓解。
- 基线生物标志物和超声参数值不能预测缓解。
- 经会阴超声测量的直肠肠壁厚度从基线至第1周的变化是第8周缓解的独立预测因子(每降低1mm的校正比值比为1.90,95%CI 1.22-2.95)。
- 在1周内未达到缓解的患者亚组分析中,直肠肠壁厚度变化的预测价值仍较高(AUC=0.77,95%CI 0.61-0.88)。
关键数值与推荐
- 临床缓解定义为患者报告结局-2≤1且无直肠出血亚评分。
- 预测因素采用多变量回归模型和受试者工作特征曲线分析评估。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bowel ultrasonography is a non-invasive imaging tool that can repeatedly monitor ulcerative colitis (UC) activity. AIM: This study aimed to determine whether early transabdominal or transperineal ultrasonography changes can predict subsequent clinical response to induction therapy in patients with UC. METHODS: This single-centre prospective study explored ultrasonographic predictors for clinical remission (patient-reported outcome-2 ≤ 1 with no rectal bleeding subscore) at week 8 in patients with active UC who underwent induction therapy, in comparison with faecal calprotectin and C-reactive protein (measured at baseline, week 1 and week 8). Predictive factors were assessed using multivariable regression models and receiver-operating-characteristic curve analysis. RESULTS: A total of 100 patients were analysed, of which 54 achieved remission at week 8. Baseline biomarker and ultrasonographic-parameter values were not predictive of remission. Contrastingly, change from baseline to week 1 in rectal bowel wall thickness measured using transperineal ultrasonography was an independent predictor of remission by week 8 (adjusted odds ratio is associated with a 1-mm decrease: 1.90 [95% confidence interval, 1.22-2.95]). In a subgroup analysis of the patients who did not achieve remission in 1 week, the predictive value of change in rectal bowel wall thickness remained high (AUC = 0.77 [95% confidence interval, 0.61-0.88]). CONCLUSION: Improvement in rectal bowel wall thickness measured using transperineal ultrasonography at week 1 predicts treatment success and potentially facilitates decision making during the early course of induction therapy in UC.
引用
- Sagami S, Kobayashi T, Aihara K, et al. Early improvement in bowel wall thickness on transperineal ultrasonography predicts treatment success in active ulcerative colitis. Aliment Pharmacol Ther. 2022. PMID: 35218038. doi:10.1111/apt.16817
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。